From Medscape Oncology

Medscape Medical News from the:

European Cancer Congress 2013 (ECCO-ESMO-ESTRO)

September 27 - October 1, 2013; Amsterdam, the Netherlands

This coverage is not sanctioned by, nor a part of the European Cancer Organization, the European Society for Medical Oncology, or the European Society for Radiation and Oncology.

Meeting Highlights at a Glance

Top News From ECC 2013 (ECCO-ESMO-ESTRO): Slideshow
Highlights include promising immunotherapeutic agents for melanoma and lung cancer; treatment trials in ovarian and breast cancer, plus a special report on global disparities in oncology.

Genomics in Practice at the 2013 European Cancer Congress
Dr. Maurie Markman looks at a few presentations from the 2013 European Cancer Congress that highlight the practical role of genetic testing in the management of cancer.

Conference News

Medscape Oncology Insights

Oncologists Initiate Upgrade of European Cancer Care
David Kerr, CBE, MD, DSc, FRCP, FMedSci; Cornelis J.H. van de Velde, MD, PhD

Prostate Cancer: Enough 'Me Too’ Drugs
Stéphane Oudard, MD, PhD;
Bertrand Tombal, MD, PhD

Bevacizumab: Mixed Results in Glioblastoma
Wolfgang Wick, MD

Ipilimumab Goes the Distance in Melanoma Survival
Antoni Ribas, MD, PhD;
Caroline Robert, MD, PhD

New ALK Agents: Lung Cancer's 'Second Miracle'?
Giorgio V. Scagliotti, MD, PhD;
D. Ross Camidge, MD, PhD

TDM-1 Heavy Hitter in Heavily Treated Breast Cancer
Joseph Gligorov, MD, PhD;
Javier Cortés, MD, PhD

TKI Hikes Survival in Recurrent Ovarian Cancer
Stanley B. Kaye, MD

HPV Head and Neck Cancer: The New Threat
Linda Brookes, MSc

 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.